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Animal derived milk which is an important part of human diet due to its high nutritional value not only
supports humans but also presents a growth environment for pathogenic bacteria. Milk may become
contaminated with bacteria through udder infections or through contact within the dairy farm environ-
ment. Infections are treated with antibiotics, with β-lactams most commonly used in veterinary medicine.
However, their frequent use leads to the emergence of β-lactam resistant bacterial strains, which causes
difficulties in the treatment of infections in both humans and animals. Detection of pathogens as well as
their antibiotic sensitivity is a pre-requisite for successful treatment and this is generally achieved with lab-
oratory-based techniques such as growth inhibition assays, enzyme-linked immunosorbent assays (ELISA)
or polymerase chain reactions (PCRs), which are unavailable in resource-limited settings. Here, we investi-
gated paper-based analytical devices (µPADs) for the presumptive detection of Staphylococcus aureus (S.
aureus) and Escherichia coli (E. coli) and their antibiotic resistant bacterial strains in milk samples. The
µPADs were fabricated on filter paper using wax printing, and then impregnated with chromogenic sub-
strates, which reacted with bacterial enzymes to form coloured products. Limits of detection of S. aureus
and E. coli and their antibiotic resistant strains in milk samples were found to be 106 cfu mL−1. Enrichment
of milk samples in a selective medium for 12 h enabled detection as low as 10 cfu mL−1. The paper
devices tested on a set of 640 milk samples collected from dairy animals in Pakistan demonstrated more
than 90% sensitivity and 100% selectivity compared to PCR, showing promise to provide inexpensive and
portable diagnostic solutions for the detection of pathogenic bacteria in resource-limited settings.
Introduction
Milk is an essential component of the human diet and forms
part of the official nutritional recommendations in many
countries. It provides nutrients such as amino acids, vitamins
and minerals that are difficult to obtain from dairy-free diets.1
In addition to being nutritious for humans and animals, milk
is also a favourable growth medium for a range of bacteria.
Dairy animals can harbour pathogenic bacteria and continu-
ously excrete them in their secretions. Milk can thus become
contaminated with pathogenic bacteria either through udder
infections, i.e. mastitis,2 or via direct contact with contami-
nated materials.3 This contaminated milk is a potential source
of transmission of foodborne pathogenic bacteria and its
nutrient-rich environment allows bacteria to proliferate rapidly
and produce toxins, thus making it an extremely vulnerable
commodity for human health.4 In spite of strict quality con-
trols, pasteurization of milk and improved health and well-
being of dairy animals in developed countries, outbreaks of
milk-borne illness have been reported.5–7 According to the
Centers for Disease Control and Prevention (CDC): contami-
nated milk, and milk products, accounted for the most hospi-
talizations relating to food-borne illnesses.8 The European
Union legislation (Regulation 853/2004) stipulates that only
milk from healthy animals can be used for human consump-
tion with a specific limit of <500 cfu mL−1 for S. aureus and
<100 cfu mL−1 for E. coli (coliforms) in raw milk for drinking
(Council Directive 92/46/EEC).9 The US Food and Drug
Administration suggests lower levels of 10–100 organisms of
S. aureus and E. coli in milk to be of public health concern.10
Compliance with such legislations can be achieved by constant
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vigilance over udder health and the quality of milk until it
reaches the consumers. This is particularly challenging in
resource-limited countries, where preventive measures are not
always followed,8 and where reliable and affordable point-of-
care diagnostic methods are lacking.
Escherichia coli and Staphylococcus aureus are major milk-
borne pathogenic bacteria that cause a wide range of diseases
including mastitis, food poisoning and gastroenteritis in both
humans and animals. Mastitis, the most costly and common
disease in dairy animals, is mainly treated with beta-lactam
antibiotics such as penicillin and cephalosporin, typically for
more than 3 days.11,12 Frequent and prolonged use of anti-
biotics in feedstock animals is one of the major reasons for
the emergence of antibiotic resistant bacterial strains. Beta-
lactam resistant strains of both E. coli and S. aureus have been
reported, posing a growing threat for the effective treatment of
infections related to these pathogens in both humans and
animals.13,14
Identification of pathogens and their antibiotic sensitivity
is a pre-requisite to tailoring effective prevention and treat-
ment plans. This is usually achieved by cell-culture based
methods and growth inhibition assays which are cumbersome,
expensive and time-consuming.15,16 Alternatively, PCR16 and
ELISA17 techniques have been used for the detection of these
pathogens in milk, but they require the availability of a dedi-
cated laboratory facility, highly trained personnel, stable
reagents, and multistep sample handling. Management of the
logistical considerations associated with sample collection and
transport to central laboratories is also required. Due to the
lack of basic infrastructure, these techniques are of limited use
in resource-poor settings.18 According to the World Health
Organization (WHO), diagnostic tests for resource-limited
environments should be affordable, sensitive, specific, user-
friendly, rapid and robust, equipment-free, and deliverable to
end-users (ASSURED).19 More recently, Land et al. proposed
REASSURED with the addition of R (real-time connectivity)
and E (ease of specimen collection and environmental friendli-
ness) to the existing ASSURED, for the design of future diag-
nostic tests to address important priorities such as global
health emergencies and antimicrobial resistance (AMR).20
Microfluidic paper-based analytical devices (µPADs) are a
relatively new diagnostic platform that may satisfy the
ASSURED and REASSURED criteria.20,21 Being inexpensive,
and simple to manufacture and operate, µPADs have attracted
significant interest as emerging alternatives to conventional
tests, showing promise for scalable, low-cost monitoring, and
user-operating analytical devices. The paper matrix, most com-
monly hydrophilic cellulose fibres, allows passive liquid trans-
port through capillary forces.22,23 Hydrophobic barriers
embedded into the fibre allow liquid flow to be confined.23 A
range of methods has been reported for the fabrication of
paper-based devices including inkjet printing,24 photolithogra-
phy,21 cutting,25 stamping,26 screen printing27 and wax print-
ing.28 Wax printing is probably the simplest and most rapid of
these fabrication techniques, requiring only a commercially
available office ‘wax’ printer, which operates like an ordinary
office printer, but instead of ink, deposits wax on the paper.
The printed paper is then heated to allow the wax to penetrate
through the paper thickness, thus generating a hydrophobic
barrier in the paper to enable control over fluid flow during an
assay.
Recently, there have been reports on μPADs for bacterial
diagnostics. Henry’s group developed μPADs with colorimetric
reactions between bacterial enzymes and chromogenic sub-
strates, i.e. chlorophenol red-β-D-galactopyranoside (CPRG) to
detect E. coli O157:H7, 5-bromo-6-chloro-3-indolyl caprylate for
Salmonella typhimurium, and 5-bromo-4-chloro-3-indolyl-myo-
inositol phosphate for Listeria monocytogenes from ready-to-eat
meat29,30 and from agricultural water samples.31 Exploiting the
same motif, μPADs were further developed for the detection of
β-lactam resistance in E. coli in water samples by measuring
the colour developed from the reaction between nitrocefin sub-
strates and the bacterial secreted β-lactamase.30 A similar
concept was also reported on μPADs for E. coli BL21 detection
from water samples.32
Globally, Pakistan is the fourth largest milk producing
country,33 and S. aureus and E. coli as well as their antibiotic
resistant strains can cause heavy losses to its dairy industry. Early
and rapid screening systems can help minimise such losses and
also help reduce the development of antibiotic resistance for
mastitis treatment. The emerging Extended Spectrum Beta
Lactamases (ESBLs) are not only able to inactivate narrow-spec-
trum antibiotics such as penicillins, and 1st- and 2nd-gene-
ration cephalosporins, but also hydrolyse 3rd, 4th and 5th-gene-
ration β-lactam antibiotics such as ceftazidime (CAZ) and cefo-
taxime (CTX).34,35 Infections caused by ESBL-producing bac-
teria are very difficult to cure, have limited treatment options,
and often result in treatment failure.36,37 Knowledge of anti-
microbial susceptibility patterns of local bacterial population
will significantly help clinicians with rapid identification of
antibiotic resistant bacterial species and prescription of appro-
priate antibiotics in a timely manner.
In this study, µPADs were explored for presumptive diagno-
sis of E. coli and S. aureus and their antibiotic-resistant strains
in milk samples employing a range of chromogenic substrates
(Table 1). For the first time, 5-bromo-6-chloro-3-indolyl
phosphate p-toluidine salt (BCIP, magenta phosphate) and
HMRZ-86 were employed on paper-based devices for the detec-
tion of S. aureus and ESBL-positive bacteria, respectively. The
developed µPADs were tested with 640 milk samples collected
from healthy animals from dairy farms in Pakistan. By com-
bining the various colorimetric assays on the μPADs, a simul-
taneous indication of the presence of particular bacteria and
their antibacterial resistance with readout can be achieved by
the unaided eye or photographing via a smartphone.
Experimental
Materials
Bacterial strains of E. coli (NCTC 12241, 11560, 13351) and
S. aureus (NCTC 12981, 12973) were obtained from Pro-Lab
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Diagnostics (UK). Nitrocefin was obtained from Merck
Millipore (UK). Chlorophenol red-β-D-galactopyranoside
(CPRG), 5-bromo-6-chloro-3-indolyl phosphate p-toluidine
salt (BCIP, magenta phosphate) or magenta phosphate,
β-galactosidase, β-lactamase and rAPid alkaline phosphatase
were all acquired from Sigma-Aldrich (UK). HMRZ-86 was pur-
chased from Bio-Rad Laboratories (UK). Filter paper
(Whatman grade 4) was bought from GE Healthcare Life
Sciences (UK). Mueller-Hinton broth and Buffered Peptone
Water broth were purchased from Oxoid Ltd, UK. Pasteurised
cow’s milk was purchased from local stores (Hull, UK).
Preparation of bacterial culture
Pure β-lactamase negative (NCTC 12241), β-lactamase positive
(NCTC 11560) and ESBL positive (NCTC 13351) E. coli strains
were cultured overnight in buffered peptone water (BPW)
supplemented with vancomycin hydrochloride (8 mg L−1).
Similarly, pure β-lactamase negative (NCTC 12981) and
β-lactamase positive (NCTC 12973) S. aureus strains were
grown overnight in Mueller-Hinton (MH) broth supplemented
with 5% sodium hydroxide (NaCl). Supplementation of the
BPW medium with vancomycin hydrochloride renders the
medium selective for E. coli, while addition of 5% NaCl in MH
broth makes the medium selective for S. aureus.31,44
Fabrication of µPADs
Designs of the desired wax features were drawn in AutoCAD
software (Student Version 2018). An array of 7 mm diameter
circles with a 0.5 mm line thickness was printed on the
Whatman paper using a wax printer (Xerox ColorQube). The
paper was then wrapped in a single layer of aluminium foil
and placed on a hot plate at 200 °C for 2–3 min. The heat
melted the wax and allowed it to pass through the paper to
create a hydrophobic wax barrier. One side of the paper was
sealed with masking tape to prevent leaking of reagents during
an experiment.
Preparation and deposition of chromogenic substrates in µPADs
Solutions of the chromogenic substrates were prepared in
HEPES buffer (0.1 M HEPES, 0.1% BSA, pH 7.5). CPRG for the
detection of E. coli was made up as a 3 mM solution according
to Bisha et al., 2014.31 BCIP for the detection of S. aureus was
prepared at 5.7 mM (the maximum concentration at which the
reagent can be dissolved in PBS without precipitation). For the
detection of β-lactam resistant strains of E. coli and S. aureus, a
solution of nitrocefin (1 mM) was prepared as described by
Boehle et al. 2017.30 HMRZ-86 was available in the soluble
form in a β-LACTA test kit (Bio-Rad Laboratories) and was used
for the detection of ESBL. For a point-of-care device to be used
under field conditions, it is desired to have minimal user inter-
vention. To this end, the chromogenic substrates were pre-de-
posited and dried onto the paper prior to use, in contrast to
previous reports where they were added in liquid form.29,31
Prior to substrate deposition, the bottom of the printed paper
was sealed with masking tape. Then, each chromogenic sub-
strate solution (6 μL) was deposited on the µPADs and allowed
to dry at room temperature for 5–10 min (visually inspected).
The µPADs were placed in a Petri dish covered with aluminium
foil to prevent light exposure, and stored at 4 °C for 1–2 days
prior to use.
Optimisation of paper-based assays
The colorimetric reactions for paper-based assays were opti-
mised using enzyme solutions prepared in PBS; alkaline phos-
phatase (0–80 mU mL−1), β-lactamase (0–0.8 mU mL−1), and
β-galactosidase (0–80 mU mL−1). The enzyme solutions were
freshly prepared at the start of each experiment.
Assays for bacterial culture, spiked milk and real milk samples
Bacterial culture. Ten-fold serial dilutions of E. coli and
S. aureus and their antibiotic resistant strains were prepared in
their respective selective enrichment media. Lysis of E. coli was
performed prior to testing using a probe sonicator (Diagenode
Bioruptor/Sonicator UCD-200) at 22 kHz for 30 s to liberate
β-galactosidase according to the protocol described by Bisha
et al.31 Alkaline phosphatase and β-lactamase are not endogen-
ous enzymes and therefore, bacterial lysis was not conducted.
To perform an assay on a µPAD, 35 µL of pathogen suspension
from each serial dilution was added to the pre-prepared µPAD
and incubated at 37 °C for 3–4 h.
Spiked milk samples. Overnight cultures of E. coli and
S. aureus and their antibiotic resistant strains were used to
prepare ten-fold serial dilutions in pasteurized cow’s milk
(local market, UK). A hundred microlitres of bacterial cell
culture suspension was mixed with 900 µL of milk sample.
The solution was then further diluted (ten-fold) in milk. For
quantification of colony forming units (cfu) per mL, 100 µL
from each serial dilution was plated in nutrient agar. Each
dilution (35 μL) was tested on the µPAD for colorimetric reac-
tions. Previous studies reported that low volume enrichment
(<1 mL) resulted in pathogen cell proliferation and an increase
in their associated enzymes and therefore a more intense
colour change and lower limit of detection were achievable.29
For this purpose, 900 µL of selective enrichment broth was
Table 1 Colour changing reactions employed herein to study the presence and antibiotic resistance of E. coli and S. aureus
Substrate Enzyme Colour change Indicative Ref.
CPRG β-Galactosidase Yellow to red-violet The presence of E. coli 29 and 31
BCIP, magenta phosphate Alkaline phosphatase Colourless to purple-mauve The presence of S. aureus 38
Nitrocefin β-Lactamase Yellow to red Antimicrobial resistance to traditional β-lactams 30, 39 and 40
HMRZ-86 ESBL Yellow to red Antimicrobial resistance to extended β-lactams 34, 35, and 41–43
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inoculated with 100 µL of each serially diluted spiked milk
sample. These enriched spiked milk samples were incubated
at 37 °C for variable periods of time, i.e. 0, 4, 8 or 12 h. After
incubation, 35 µL from each enriched sample was tested on
the µPAD with colorimetric reactions.
Raw milk samples. Following ethical clearance by the
Institutional Ethical Committee (IEC) in the National
Institute for Biotechnology and Genetic Engineering (NIBGE),
Faisalabad (Pakistan), raw milk samples were collected from
640 dairy animals having apparently healthy udders (228
buffaloes and 412 cows in different dairy farms in rural areas
of Faisalabad, Pakistan). Before sampling, initial few drops
of milk were discarded, and teat ends were disinfected with
cotton swabs soaked in 70% ethanol and allowed to dry. Each
milk sample (5–10 mL) was collected directly in a sterile
screw cap bottle from all quarters. The samples were kept on
ice and transported to the laboratory for analysis. For enrich-
ment of bacteria, 1 mL of the milk sample was diluted with
9 mL of BPW containing specific supplements and incubated
at 37 °C for 12 h (Table S1, ESI†). Specific supplement
encourages growth of selective bacteria only. After incu-
bation, the samples were tested using µPADs for the detection
of S. aureus and E. coli and their β-lactam resistant strains as
discussed above.
Visual detection and data analysis
Colorimetric results were analysed through visual inspection
of the µPAD at 3–4 h after sample deposition. The presence of
E. coli in the samples was determined by a change in the
colour of CPRG embedded in the µPADs from yellow to red-
violet.29,31 Similarly, S. aureus was detected by a change in the
colour of BCIP embedded in the µPADs from colourless to
mauve/purple.38 A change in the colour of nitrocefin24 and
HMRZ-8635,41–43,45 embedded in the µPADs from yellow to red
are the indicatives of β-lactamase and ESBL positive bacteria,
respectively.
Semi-quantitative analysis of the colorimetric end results
was performed according to the previously reported protocol
by Boehle et al.30 Briefly, following the assay, Petri dishes con-
taining the µPADs were placed inside a light box (16 cm ×
16 cm × 16 cm) to avoid light interference during image
capture. The camera part of the smart phone (Vodafone 890N,
operated with flash) was placed between the slit of the light
box (2 cm × 5 cm) to obtain images. The images were analysed
using ImageJ freeware (National Institute of Health, USA), fol-
lowing the protocol previously described.24 Initially, the
images were processed through a Red Green Blue (RGB) stack
and the Green channel was selected as it is the complementary
colour of red, which is the end point colour of all reactions
except the S. aureus experiment which was mauve/purple.
Although the complementary colour of mauve/purple is yellow,
it gave a relatively high sensitivity with the green image
amongst the RGB stack. Therefore, it was also analysed
through the green channel. Next, the image was inverted.
Circles were drawn to outline the measurement areas within
the reaction zones. Utilising the “Measure” tab under
“Analyze”, the average colour intensity within the defined
areas was obtained and further analysed with Microsoft Excel.
The colour intensity of µPADs containing water was also ana-
lysed as a blank: the colour intensity of µPADs containing
samples was normalized by subtracting the colour intensity of
µPADs containing water. Normalised data were processed in
Microsoft Excel to obtain mean and standard deviations from
three separate repeats (n = 3).
UV-vis spectrophotometric detection of colorimetric reactions
UV-vis spectrophotometric analysis of colorimetric reactions
employed for μPADs was performed on the same reactions
using microtitre plates and a UV-vis plate reader (NanoDrop™
Lite Spectrophotometer, Thermofisher Scientific). For this
purpose, 100 µL of ten-fold serial dilutions of S. aureus and
E. coli and their β-lactam resistant bacterial strains were
reacted with 100 µL of their respective chromogenic substrates
whose concentrations were similar to those used on µPADs.
The microtiter plate was then incubated at 37 °C for 2 h.
Following this, absorbance at various wavelengths was
measured; 595 nm for the CPRG reaction, 405 nm for the BCIP
reaction, and 490 nm for the nitrocefin and HMRZ-86
reaction.
Polymerase chain reactions (PCR)
DNA was extracted from enrichment broth using a GeneJET
Genomic DNA Purification Kit according to the manufacturer’s
instructions. A Nano-drop system (ND-2000C, Thermofisher
Scientific) was employed to quantify the concentration and
purity of the extracted DNA. The primers used during PCR are
summarised in Table S2, ESI.† All the reactions were carried
out to a final volume of 50 µL under the following conditions.
Initial denaturation at 94 °C for 2 min, followed by 35 cycles of
denaturation at 94 °C for 1 min, annealing (at the temperature
summarised in Table S2, ESI†) for 1 min, and extension at
72 °C for 2 min. Final extension was performed at 72 °C for
10 min to complete the reaction. Amplified PCR products were
detected by electrophoresis on 1.5% agarose gel and visualised
using a gel documentation system (Gel Doc™ EZ Imager, Bio-
RAD) and photographed. A GeneRuler 1kb DNA ladder
(Thermo Scientific) was included in each run.
Results and discussion
Paper-based assays employing colorimetric reactions between
bacterial enzymes and their corresponding chromogenic
substrates
The development of the paper-based assays initially involved
the use of enzyme solutions, rather than enzymes derived
from the bacteria, to confirm the feasibility of enzyme–sub-
strate reactions on the paper matrix. For optimisation of the
reaction conditions, different dilutions of pure bacterial
enzymes were freshly prepared at the start of each experiment.
The lowest β-galactosidase concentration to produce a dis-
tinguishable colour change from yellow to red-violet was 0.02
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U mL−1 (Fig. 1S(a), ESI†), comparable to 0.03 U mL−1 reported
for β-galactosidase.46 The lowest enzyme concentration to
show a distinctive colour change for β-lactamase assay was
0.1 mU mL−1 (Fig. 1S(b), ESI†). The discrepancy with the value
of 10 mU mL−1 reported by Boehle et al.30 may plausibly be
due to different sources of beta-lactamase employed for the
reaction.
For S. aureus detection, the reaction between solutions of
BCIP and alkaline phosphatase solution was first attempted
on paper. Utilising 3 mM BCIP, a characteristic colour change
from colourless to mauve/purple was successfully observed at
≥0.006 U mL−1 of alkaline phosphatase (Fig. 1S(c), ESI†). This
demonstrates a novel paper-based assay for S. aureus detection
via bacterial alkaline phosphatase and its corresponding chro-
mogenic substrate BCIP (magenta phosphate).
Testing of the developed μPADs with bacterial culture
Having successfully developed μPADs for the detection of bac-
terial enzymes from enzyme solutions, the devices were next
tested with live bacteria populations obtained from cell cul-
tures in their respective growth media. Ten-fold serial dilutions
of different strains of E. coli and S. aureus were prepared in
their respective selective broths and reacted with their relevant
chromogenic substrate on the µPADs.
In order to determine the presence of β-galactosidase,
E. coli was lysed prior to testing on the developed paper device
as β-galactosidase is produced inside E. coli cells and is not
secreted into the surrounding medium. A distinctive colour
change from yellow to red-violet when reacting with CPRG was
observed at an E. coli concentration of ≥3.6 × 106 cfu mL−1
(Fig. S2(a), ESI†), in good agreement with the 3.8 × 106 cfu
mL−1 value detected on µPADs developed by Boehle et al.30
In contrast to β-galactosidase, alkaline phosphatase is
excreted from S. aureus cells into the surrounding medium.
The reaction between S. aureus secreted alkaline phosphatase
and BCIP was therefore carried out without cell lysis
(Fig. S2(b), ESI†) employing the same device shown in
Fig. S1(c), ESI.† A distinguishable colour change from colour-
less to mauve/purple was observed at a concentration exceed-
ing 3.6 × 106 cfu mL−1. To the best of our knowledge, this is
the first time the detection of S. aureus was demonstrated on a
paper device based on the reaction between bacteria secreted
enzyme alkaline phosphatase and 5-bromo-6-chloro-3-indolyl
phosphate p-toluidine salt.
Next, the efficiency of the developed µPADs on detecting
the β-lactam resistant strain of E. coli was examined using the
colorimetric reaction between nitrocefin and beta-lactamase to
produce a characteristic colour change from yellow to red. No
cell lysis was performed prior to the reaction, even though a
marginal 5% increase in colour intensity on µPADs tested with
lysed E. coli was observed when compared to that of intact
cells.30 As expected, no colour change occurred for the
β-lactam susceptible strain of E. coli, where no β-lactamase was
produced by the bacterial enzyme (Fig. S3(a), ESI†). For the
β-lactam resistant strains, a colour change occurred at concen-
trations ≥106 cfu mL−1, in good agreement with ≥3.8 × 106
cfu mL−1 bacteria reported from µPADs tested with different
β-lactam resistant bacteria in wastewater and sewage.24 The
same device tested with a β-lactam resistant strain of S. aureus
detected the colour change at ≥1.3 × 106 cfu mL−1 (Fig. S3(b),
ESI†).
The experiments confirmed the feasibility of μPADs for
E. coli and the β-lactam resistant strain of E. coli, as well as
feasibility for the detection of S. aureus employing the reaction
between their secreted alkaline phosphatase and the chromo-
genic BCIP substrate. In addition, a β-lactam resistant strain of
S. aureus was effectively detected using the nitrocefin-
embedded μPAD. Distinctive colour changes were observed in
all cases at bacterial levels of ≥106 cfu mL−1.
Cross reactivity study of μPADs for S. aureus and E. coli
The colorimetric assays employed for the developed paper
devices utilised enzymes which could also be produced by
other bacteria, and hence a compromised specificity might be
expected when performed under field conditions. In laboratory
settings, specific supplements can be added into the enrich-
ment media in order to promote the growth of target bacteria,
whilst simultaneously inhibiting the growth of other compet-
ing bacteria. Herein, vancomycin hydrochloride was utilised to
support the growth of E. coli, and to suppress the growth of
S. aureus. Similarly, the high salt content present in MH broth
only permits S. aureus to grow. A cross-reactivity study between
the two assays was carried out after incubating the bacteria in
selective enrichment broths. The colour change was only
observed when the correct pair of bacterial enzyme and
specific substrate was present, with no false positive results
found from the two bacterial species (Fig. 1). Although cross
reactivity can be eliminated in laboratory analysis using a
growth inhibitor to suppress competing bacteria, this can be
problematic in field tests and false positive results are inevita-
ble. Nevertheless, the method can still be suitable as an initial
screening test providing impetus for further testing and confir-
mation to be conducted. Further investigations will include
protocols to minimise other related contaminating bacteria in
the sample using selective enrichment media.
μPADs for the differentiation of β-lactam resistant and ESBL
resistant bacteria
Next, we aimed to develop paper-based assays for the detection
of ESBL bacteria which not only show resistance to penicillins,
such as cephalosporins and aztreonam, but also to other
classes of antibiotics, such as aminoglycosides, cotrimoxazole,
tetracycline and fuoroquinolones.
Nitrocefin was reported as a suitable substrate for the detec-
tion of ESBL bacteria. A colour change from yellow to red
could be observed on the developed μPAD when pathogen con-
centrations exceeded 106 cfu mL−1 for both β-lactam resistant
E. coli and ESBL resistant E. coli (Fig. S4(a), ESI†) as nitrocefin
cannot differentiate between these two groups.36 As such, a
specific chromogenic cephalosporin, HMRZ-86, was herein
exploited as a selective chromogenic substrate embedded on
the μPAD to detect ESBL-resistant bacteria. A carboxypropyl-
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oxyimino group that binds to the side chain at position 7 in
compound protects the β-lactam ring from a range of
β-lactamases, but not from extended-spectrum β-lactamases
(ESBLs).45 In contrast to nitrocefin embedded μPADs, a colour
change from yellow to red only occurred from the presence of
ESBL-resistant E. coli at concentrations exceeding 106 cfu mL−1
(Fig. S4(b), ESI†). This development can be applied to real
samples where differentiation of antibiotic resistant E. coli
strains can prove to be crucial.
The sensitivity of the paper-based reactions performed on the
developed μPADs was validated against the UV-visible spectro-
photometry results obtained from the same liquid-phase reac-
tions conducted in conventional microtitre plates. A comparable
level of 106 cfu mL−1 bacteria detection observed from the absor-
bance values of the spectrophotometric assay confirming the via-
bility of the developed μPADs (Fig. S5–S7, ESI†), and demonstrat-
ing a cost-effective approach of µPADs coupled with a smart
phone for the detection of bacteria in samples without the need
for sophisticated laboratory equipment and trained staff.
μPADs for the analysis of bacterial spiked-milk samples
Having demonstrated the viability of the paper devices for the
detection of E. coli and S. aureus and their antibiotic resistant
strains from bacterial culture media, the μPADs were next
tested with milk samples spiked with bacteria in a range of
ten-fold serial dilutions.
First, the μPAD embedded with BCIP was investigated with
milk samples spiked with S. aureus. A colour change from the
reaction between S. aureus secreted alkaline phosphatase and
BCIP was visually detectable at a concentration exceeding 4.5 ×
106 cfu mL−1 (Fig. 2a), similar to the result previously obtained
from S. aureus in culture media. The nitrocefin reaction also
worked well distinguishing between β-lactam susceptible and
β-lactam resistant strains of S. aureus spiked into milk samples
(Fig. 2b). The resistant strain of S. aureus revealed a red colour
at concentrations exceeding 4.5 × 106 cfu mL−1. These results
showed the successful paper-based detection of S. aureus and
its β-lactam resistant strain from spiked milk samples, which
can potentially be utilised for detecting such pathogenic bac-
teria from real milk samples and other complex matrices.
Fig. 1 Cross reactivity study for assessing the selectivity of each
enzyme–substrate pair. (a) A reaction between the CPRG substrate and
the enzyme β-galactosidase from E. coli yields a colour change from
yellow to red-violet. (b) A purple-mauve colour product is afforded from
the reaction between the BCIP substrate and the enzyme alkaline phos-
phatase from S. aureus. (c) μPADs embedded with CPRG (top row) and
BCIP (bottom row) tested with control (left-hand column), E. coli
(middle column) and S. aureus (right-hand column). Colour change was
observed only when a specific substrate–enzyme pair was present. Level
of bacteria = 106 cfu mL−1.
Fig. 2 (a) Reaction on the µPAD between the BCIP substrate (5.7 mM)
and alkaline phosphatase excreted from S. aureus spiked into milk. A
colour change was detectable at 4.5 × 106 cfu mL−1, and no colour
change was observed at 4.5 × 105 cfu mL−1. (b) Reaction on µPAD
between the nitrocefin substrate and live bacteria of β-lactam resistant
and β-lactam susceptible strains of S. aureus. Only the resistant strain
yields a colour change when concentrations exceed 106 cfu mL−1
(n = 3).
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The nitrocefin-embedded μPAD tested with E. coli spiked
into milk samples showed a colour change to red for the
resistant strain at a concentration ≥2.4 × 106 cfu mL−1
(Fig. 3), similar to the observation from the culture broth.
Boehle et al. also detected a colour change in their nitrocefin
embedded µPADs tested with wastewater and sewage with
≥3.8 × 106 cfu mL−1 bacteria, but not with lower concen-
trations.30 This shows the versatility of the paper-based
β-lactamase-nitrocefin assays for the detection of β-lactam
resistant E. coli at ca. 106 cfu mL−1, regardless of the com-
plexity of the matrices.
The assessment of the HMRZ-86 impregnated μPAD with
spiked milk samples also demonstrated the specificity to the
EMBL-resistant strain of E. coli at a similar visual detection
level of 2.7 × 106 cfu mL−1 as found in pure culture samples
(Fig. 4).
However, the reaction between CPRG and β-galactosidase
from lysed E. coli was not successfully tested with spiked milk
samples (Fig. S8, ESI†). It is postulated that β-galactosidase
released by the bacteria might have hydrolysed a large amount
of lactose contained in the milk samples, and therefore only a
small quantity of β-galactosidase was available to react with
embedded CPRG.
Following on, pre-enrichment of spiked milk samples was
attempted in order to supply nutrients and to encourage bac-
teria growth over a period of a few hours prior to testing. The
supplements contained within the enrichment media selec-
tively promote the growth of target bacteria, whilst simul-
taneously inhibiting the growth of other competing bacteria.
Thus, the desired bacteria can be brought to a concentration
level that is detectable through the colorimetric reaction on
the μPADs. Fig. 5 depicts the colorimetric results obtained from milk
samples spiked with E. coli and S. aureus and their antibiotic
resistant strains after pre-enrichment. Levels of bacteria as low
as 10 cfu per 1 mL of the spiked milk sample could be
detected following 12 or 16 h of pre-enrichment in their
respective selective broths. This suggests that the sensitivity of
the paper-based assays can be vastly improved by including a
bacterial pre-enrichment step. Pre-enrichment amplifies the
analyte target, and when combined with selective growth
media, it reduces the growth of unwanted bacteria in samples
that could contribute to false positive results as also reported
previously.24,31 This step only required an incubator, which is
commonly used in microbiology laboratories. With further
investigations, a suitable pre-concentration step can be
included in the platform for field tests. The final detection per-
formed on µPADs can offer a simple, cost-effective, and easy-
to-interpret solution for the screening of major milk borne
pathogens. The entire process, overnight pre-enrichment and
colorimetric detection, can be performed within one day, and
it allows the detection of bacterial contamination as low as 10
cfu mL−1 from the initial sample.
μPADs for the analysis of bacteria in raw milk samples
The ultimate goal of this present study was to develop a
simple, cost-effective and user-friendly device for the detection
Fig. 3 Reaction on the µPAD between the nitrocefin substrate and live
bacteria of β-lactam resistant and β-lactam susceptible strains of E. coli.
Only the resistant strain yielded a colour change when concentrations
exceeded 106 cfu mL−1 (n = 3).
Fig. 4 Detection of ESBL E. coli from spiked milk samples employing
the HMRZ-86 impregnated µPAD. A distinctive colour change from
yellow to red was observed from the ESBL resistant strain of E. coli at 2.7
× 106 cfu mL−1 (n = 3).
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of pathogenic bacteria causing mastitis suitable for resource-
poor areas in the developing countries. The viability of the
developed paper devices was therefore examined for the detec-
tion of S. aureus and E. coli with raw milk collected from a
group of cattle and buffaloes in Pakistan. The samples were
collected from healthy animals from the field. Due to very low
level of bacteria from the samples, pre-enrichment with selec-
tive media was required to increase the number of bacteria to
meet with the detectable level of the paper devices (ca. 106 cfu
mL−1) previously observed from bacterial spiked milk samples.
In order to achieve this, a milk sample (10 v%) was mixed with
selective media (90 v%) and incubated at 37 °C for 12 h. This
step not only increased the bacterial level, but also diluted the
lactose concentration in the samples, thereby diminishing the
consequent competing lactose hydrolysis which was proble-
matic in the β-galactosidase-CPRG reaction previously observed
in E. coli spiked milk samples. Subsequently, the pre-enriched
samples were analysed on μPADs and PCR gene analysis was
conducted for result confirmation (Fig. 6a and b).
Out of 640 milk samples, µPADs detected 77 samples with
E. coli positive (84 samples confirmed by PCR), and 129
samples with S. aureus positive (143 confirmed by PCR) as
summarised in Table 2. These results suggested that the sensi-
tivity of our developed µPADs was higher than 90%. The posi-
tive results obtained on µPADs also showed positive from PCR,
indicating that the µPADs were also 100% specific.
Fig. 5 Photographs and colour intensity analysis of milk samples spiked with various bacteria after 12 h enrichment (n = 3).
Fig. 6 Left: Detection of pathogenic bacteria employing µPADs; (a) E. coli. (b) S. aureus. (c) Beta-lactam resistant E. coli. (d) Beta-lactam resistant
S. aureus. N = negative control that contains enrichment broth without any sample/bacteria; P = positive control that contains enrichment broth
with pathogenic bacteria or their β-lactam resistant strains; 1–6 = samples collected from field. Right: gel electrophoresis of various PCR products;
N = negative control that contains no DNA template; P = positive control that contains DNA of pathogenic bacteria or their β-lactam resistant
strains; Lanes 1–6 = samples collected from the field.
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Beta-lactam is the most widely used class of antibiotics in
veterinary medicine. As a result, β-lactam resistant pathogens
are very common in livestock. For the detection of β-lactam re-
sistance in the E. coli- and S. aureus-positive milk samples,
enrichment cultures were sub-cultured in BPW supplemented
with cefotaxime (2 μg mL−1) and tested on nitrocefin
embedded µPADs. Beta-lactam resistance in the same samples
was also confirmed by PCR through amplification of the
blaTEM gene (Fig. 6(c and d)). The µPAD detected β-lactam
resistant pathogens in 67% and 62.7% of E. coli and S. aureus
isolates, respectively, without false positive results confirmed
by PCR (Table 3). Therefore, the µPAD accurately detected
β-lactam resistant isolates.
We have shown a successful implementation of paper-
based colorimetric assays for the detection of E. coli and
S. aureus and β-lactam resistant strains in milk samples that
could be achieved within a day. The present setup required no
sophisticated equipment, and yet yielded similar sensitivity
and selectivity to the molecular diagnostic technique of PCR
for results obtained from 640 raw milk samples. In
developing countries like Pakistan, dairy farms are located in
remote and resource limited areas and local veterinary diag-
nostic laboratories are not equipped with sophisticated equip-
ment like micro-plate readers, thermal cyclers, etc., and they
tend to have only bacterial culture facilities such as incubators
and simple microscopes.1,47 In these laboratories, routine
identification of bacteria and their antibiotic sensitivity is
usually carried out by their culture characteristics (less
specific) and growth inhibition assays (i.e. analysis of bacterial
growth in the presence of antimicrobial agents), which give
results in 2–4 days.
Conclusions
In the present study, paper-based assays have been devised for
the detection of S. aureus and E. coli and their antibiotic resist-
ant strains in milk samples, with similar sensitivity to the
sophisticated laboratory-based technique, UV-vis spectropho-
tometry. Employing specific chromogenic substrates, colour-
change reactions on μPADs have successfully distinguished
specific bacteria without cross-reactivity between their
β-lactam susceptible and β-lactam resistant strains. They also
showed, for the first time, a successful differentiation between
ESBL resistant and β-lactam resistant strains. The paper
devices showed ≥90% sensitivity and 100% selectivity, com-
pared to the advanced and sophisticated PCR method, demon-
strating a cost-effective platform for the presumptive diagnosis
of bacteria in milk, especially in resource limited areas.
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